This Justification (J&A) opportunity from New Mexico was posted on August 27, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Production of Clinical Grade Alzheimer's Vaccine in FDA-Certified GMP Facility for Phase 1A/1B Clinical Trial

Awarded

60-U6900-25-CP427State & Local

Submission Closed09/25/2025

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Sterile Surgical Lubricant SupplierThis subcontract involves the supply of sterile, bacteriostatic, latex-free, and water-soluble surgical lubricant for prime contractors supporting Department of Defense Medical Supply Chain projects. The supplier is responsible for manufacturing or sourcing the lubricant according to NSN 6505-01-626-5774, with a specific delivery requirement of three boxes containing 144 units of 2.7g foil packets each. Strict adherence to regulatory and quality standards is mandatory, including FDA regulations, MIL-STD-2073-1E packaging guidelines, and Medical Marking Standard No. 1. Additionally, the supplier must ensure rigorous temperature control between 20 and 25 degrees Celsius to maintain product integrity. The opportunity is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Gasket Manufacturing and SupplyThis subcontract involves the manufacture and supply of 228 specialized gaskets for prime contractors supporting DLA Distribution supply contracts. The deliverables must be produced according to NSN/FSC 014351113/5330 specifications and adhere to MIL-STD-129 and MIL-STD-2073-1E standards for packaging and marking. A critical restriction is placed on the production process, as additive manufacturing is prohibited unless explicit authorization is granted by the contracting officer and ESA. Managed by the Department of Defense under the DLA Weapons Support Land Supplier Opns Vehicle Spt, the contract falls under NAICS code 325412. Performance will take place in New Cumberland, Pennsylvania. The solicitation was posted on November 6, 2026, with a response deadline of November 16, 2026.

DLA WEAPONS SUPPORT LAND SUPPLIER OPNS VEHICLE SPT

POSTED

DEADLINE

Supply of Self-Locking Hexagonal Nuts (NSN 5310-00-994-1670)This subcontract involves the supply of 78 self-locking hexagonal nuts, identified by NSN 5310-00-994-1670, to support prime contractors for the DLA Weapons Support ASC Commodities Division. The materials must be delivered FOB Origin to the DLA Distribution DDSP New Cumberland Facility in Pennsylvania. All supplied items are required to comply with the Buy American Act. Strict adherence to military standards is mandatory for this contract, including packaging per MIL-STD-2073-1E and marking per MIL-STD-129. Quality assurance will be conducted using zero-based sampling in accordance with MIL-STD-1916 or ASQ H1331. The solicitation was posted on November 6, 2026, with a response deadline of November 13, 2026.

DLA WEAPONS SUPPORT ASC COMMODITIES DIVISION

POSTED

DEADLINE

Maropitant Citrate Tablet ManufacturerThis subcontract involves the manufacture of FDA-regulated Maropitant Citrate 160mg tablets for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The scope of work encompasses the full production cycle, including the chemical synthesis of the active pharmaceutical ingredient, formulation, tablet compression, and primary packaging into blister packs of four tablets per perforated sheet. To ensure quality and regulatory compliance, the manufacturer must utilize pharmaceutical-grade tablet presses and operate within cGMP-compliant facilities. The final deliverable consists of four packages of tablets that adhere to all medical specifications and maintain a minimum shelf-life of 36 months. This project falls under NAICS code 325412 and is performed at an APO location. Interested parties should note the response deadline of November 12, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Varicella Virus Vaccine ManufacturerThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA requires a manufacturer to provide live, lyophilized Varicella Virus Vaccine and corresponding diluents. The manufacturer must possess the necessary lyophilization equipment and FDA approval to produce the vaccine, ensuring a total shelf life of 18 months. Each delivery unit consists of one package containing 10 vaccine vials and 10 diluent vials. All packaging and labeling must strictly adhere to MIL-STD-2073-1E and Medical Marking Standard No. 1B. The place of performance for this contract is located in Niagara Falls, New York. Interested parties should note the response deadline of November 12, 2026, for this pharmaceutical supply requirement under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sterile Sodium Chloride and Hypodermic Needle SupplierThis subcontract, managed by the Department of Defense Medical Supply Chain MD SURG FSF, involves the supply of pre-filled sterile saline and sterile hypodermic needles to prime contractors. The specific requirements include 3 ml of 0.9 percent sodium chloride and 18 GA x 1.50 inch hypodermic needles. All provided materials must be FDA approved medical grade and adhere to a strict, non-extendable shelf-life of 12 months. The contract is categorized under NAICS code 325412 and specifies Montevideo as the place of performance. Interested parties should note the posting date of November 6, 2026, with a response deadline set for November 12, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Magnesium Sulfate Oral GranulesThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture or sourcing of Magnesium Sulfate oral granules for prime contractors. The specific requirements call for 495MG/5GM oral granules packaged in 454GM bags, with delivery consisting of one case containing 12 bags. A critical quality standard is the requirement for a non-extendable shelf life of 36 months. Compliance is mandatory regarding the Buy American Act, DLA Packaging Requirements RP001, and Medical Marking Standard No. 1. The project is categorized under NAICS code 325412, with the place of performance located at JBPHH in zip code 96860. Interested parties must adhere to the response deadline of November 12, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Isopropyl Alcohol USP (99%)This subcontract involves the supply of 99% Isopropyl Alcohol for prime contractors working on Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required product must be OTC-grade, meet USP standards, and be provided in 16 oz containers. To ensure product integrity, the supplier must maintain storage temperatures between 20 and 25 degrees Celsius in accordance with USP controlled room temperature standards. The selected supplier is responsible for providing Material Safety Data Sheets and ensuring full USP compliance. Delivery of the bottled alcohol is required FOB Destination to the specified place of performance. This opportunity is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Isoniazid Tablets (USP 300 MG)This subcontract involves the supply of USP 300 MG Isoniazid Tablets to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The selected provider must manufacture or wholesale tablets that adhere to USP standards, ensuring a non-extendable shelf life of 36 months. All production and storage must occur within FDA-regulated pharmaceutical facilities maintained at medical controlled room temperature, with deliveries consisting of two bottles of 100-count tablets. The opportunity is categorized under NAICS code 325412 and is associated with a place of performance in FPO 96678. Interested parties must adhere to the timeline established by the posting date of November 6, 2026, with a response deadline set for November 12, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHLORINE TEST REAGENT

Solicitation # SPE2DS-27-T-1528

Solicitation SPE2DS-27-T-1528, issued by the Defense Logistics Agency, is for the procurement of DPD Total Chlorine Reagent under NSN 6550-01-460-7597. The requirement consists of powder pillows with a 10 ML sample size, issued in packages of 100 units each. The total quantity requested is 101 packages, with delivery required within 20 days. Delivery is FOB Destination, with shipments directed to the USS Santa Barbara LCS 32 and the USS Hopper DDG 70. The reagents must have a non-extendable shelf life of 60 months, and no more than 8 months may have elapsed from the date of manufacture to the date of government delivery. Packaging must be commercial and sealed to prevent damage, adhering to Medical Marking Standard No. 1 and MIL-STD-129. Hazardous materials must be labeled according to the Hazard Communication Standard and packaged per TQ requirement IP025. All payment requests and receiving reports must be processed electronically through the Wide Area WorkFlow system. The contract incorporates various FAR and DFARS clauses, including requirements for safeguarding covered defense information and compliance with the Buy American Act.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0256

Solicitation SPE2DP-27-T-0256, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Isopropyl Alcohol USP (rubbing alcohol). The required product must have a concentration of 99% Isopropanol and be issued in bottles containing 473 milliliters, 1 pint, or 16 ounces. The contract specifies a delivery period of 20 days after receipt of order, with the place of performance located in FPO, ZIP 96692, and terms set as FOB Destination. Inspection and acceptance will occur at the destination per FAR 52.246-2. Due to the highly flammable nature of the material, the contract mandates strict hazardous materials compliance. This includes providing a current Material Safety Data Sheet (MSDS) via the DLA electronic mailbox and accompanying every shipment. Packaging must adhere to TQ requirement IP025, MIL-STD-129, and DLAI 4145.3 for military aircraft shipments, while labeling must comply with 49 CFR, 29 CFR, and Medical Marking Standard No. 1. The contractor must provide a signed certification of package configuration on the DD Form 250 and maintain packaging test reports for three years. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and adherence to the Buy American Act and NIST SP 800-171 cybersecurity standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

RABIES VACCINE, VETERIN

Solicitation # SPE2DP-27-T-0253

Solicitation SPE2DP-27-T-0253, managed by the DLA Medical Supply Chain Pharm FSA, is for the procurement of one package of 50 units of IMRAB 3 veterinary rabies vaccine. The required product is a thimerosal-free, killed virus, 3-year vaccine (NSN 6509-01-526-5369) manufactured by Boehringer Ingelheim Animal Health USA. Due to the nature of the drug, it must be stored refrigerated between 2-8 degrees Celsius and must not be frozen. The item has a non-extendable shelf life of 24 months. Delivery is required within 84 days after order (ADO) with FOB Destination terms, with the inspection and acceptance points also set at the destination. The shipment is destined for the USA Med Mat Ctr EUR in Kaiserslautern, Germany. Packaging must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, and the contractor must provide a Safety Data Sheet prior to award. Administrative requirements include the use of the Wide Area Workflow (WAWF) system for invoicing and adherence to various FAR and DFARS clauses, including those regarding hazardous material identification, cybersecurity safeguarding, and the Buy American program.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days

AI Contract Overview

This contract involves the production of clinical-grade Alzheimer's vaccine within an FDA-certified Good Manufacturing Practice (GMP) facility to support a Phase 1A/1B clinical trial conducted at the University of New Mexico. The project is partially funded by the New Mexico HED Technology and aims to ensure the vaccine meets rigorous quality standards necessary for human testing. The contract's value ranges from $500,000 to $2,000,000, reflecting the scope of manufacturing and quality assurance activities required for the trial. The solicitation was posted on August 27, 2025, with a response deadline of September 25, 2025. The work will be performed in New Mexico, under the auspices of the University of New Mexico Hospital, with primary contact being C. Lizardi from the Department MGM. The initiative emphasizes collaboration between the university and manufacturing entities to advance Alzheimer's research, with detailed procurement information available through the New Mexico State Procurement Portal.

General Info

Agency

University Of New Mexico/Hospital

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

NM, USA

Set-Aside

NONE

Documents

sole-source-justification

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseAwarded

PostedAug 27

Solicitation

AwardedNov 8

Contract was awarded

Submission Closed

09/25/2025

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyUniversity Of New Mexico/Hospital

Contacts1 person available

OfficeN/A

Organization / AgencyUniversity Of New Mexico/Hospital

Office AddressN/A

Contacts

C. LizardiDepartment MGM

contact@example.gov

+1 (555) 000-0000

Full Description

THIS PO IS RELATED TO PRODUCING THE CLINICAL GRADE OF ALZHEIMER’S VACCINE IN A FDA-CERTIFIED GOOD MANUFACTURING PRACTICE (GMP) FACILITY FOR THE PHASE 1A/1B CLINICAL TRIAL TO BE DONE AT THE UNM. THIS STUDY IS PARTIALLY FUNDED BY THE NEW MEXICO HED TECHNOLO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS